Why GLP-1 is trending in weight loss right now GLP-1 is getting a lot of buzz in the weight loss world for its effectiveness in managing weight and boosting metabolic health
Patel: Lecture, educational and advisory related honoraria from AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Napp Pharmaceuticals, Novo Nordisk, Sanofi, MSD and Takeda
Medicare does not currently cover obesity related medications--though drugmakers are furiously lobbying Congress for access to the 65 million older and disabled people insured through Medicare
Diabetes is a national and worldwide public health problem, with a reported global prevalence of 10.5% and a prevalence of 12.6% in Mexico.13 The high prevalence of this chronic-degenerative disease results in important healthcare costs in Mexico and accounts for 14% of deaths
Our Metabolic Assessment Process Before initiating GLP-1 therapy, we conduct a thorough metabolic evaluation
FDA-Approved GLP-1R Obesity Medications (As of February, 2025) GLP-1 Treatments: Results, Side Effects, and Lifestyle Factors In terms of weight loss in people, GLP-1 drugs have demonstrated up to a 15-20% weight loss in individuals